Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To evaluate the efficacy of SSR411298 200 mg daily compared to placebo as adjunctive treatment for persistent cancer pain, as measured by the change from baseline (baseline = average pain intensity between Visit 1 (Day 7) and Visit 2 (Day 1) to end of treatment (end of treatment = average pain intensity during Week 4) in the Numeric Rating Scale (NRS)
Critère d'inclusion
- Cancer Pain,daganatos fájdalom